期刊文献+

慢性肾功能衰竭患者血清粒系集落刺激因子水平观察(英文)

Serum granulocyte colony-stimulating factor in patients with chronic renal failure
原文传递
导出
摘要 目的 探讨粒系集落刺激因子 (G CSF)的调节机制及代谢途径。方法 本文运用酶联免疫吸附试验 (ELISA)检测 61例慢性肾功能衰竭 (CRF) +/ 血液透析患者血清G CSF水平。结果 CRF患者血清G CSF水平明显升高。CRF非血透患者血清G CSF检出率为 80 65% ,血清G CSF水平为566 4 0± 2 0 7 98ng/L。CRF血透患者G CSF检出率为 93 33% ,血透前和血透后G CSF水平分别为 12 55 36±611 2 5ng/L和 1151 61± 599 4 7ng/L。血透组G CSF水平略高于非血透组 ,但两组无明显差异。血透前与血透后患者G CSF水平无明显差异。进一步分析表明 ,G CSF水平与WBC ,BUN或Scr水平无关 (P >0 0 5)。结论 CRF患者血清G CSF水平升高可能是由于肾功能不全导致G CSF清除减少或 /和G CSF产生增加。 Objective To gain a better understanding of the regulatory mechanism and kinetic behaviour of granulocyte colony-stimulating factor (G-CSF).Methods An enzyme-linked immunosorbent assay (ELISA) method was used to detect serum G-CSF in 61 patients with chronic renal failure±long-term hemodialysis and 30 normal controls. Results Serum G-CSF levels in CRF patients were significantly higher than in normal controls. Eighty percent of patients had detectable G-CSF and serum G-CSF levels were 566.40±207.98?ng/L in non-hemodialyzed (non-HD) patients. The detectable percentage in hemodialyzed patients was 93.33%, serum G-CSF levels in pre-HD and post-HD patients were 1255.36±611.25?ng/L and 1151.61±599.47?ng/L respectively. Serum G-CSF levels in HD patients were slightly higher than in non-HD patients, but no significant difference was found between the two groups. No difference was found between the G-CSF values obtained in pre-HD and post-HD patients. There was no relationship between G-CSF levels and WBC, BUN or Scr (P>0.05).Conclusion The high value of G-CSF in patients with CRF may be caused by a decrease in G-CSF clearance and/or an increase in G-CSF release.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2001年第6期36-39,104,共5页 中华医学杂志(英文版)
基金 theNationalScienceFoundationofChina (No .39470 318) the 9thFive YearPlanNationalProject (No .95 6 90 117)andHuYinzhouFound
关键词 粒系集落刺激因子 慢性肾功能衰竭 血透 granulocyte colony-stimulating factor · chronic renal failure · hemodialysis
  • 相关文献

参考文献17

  • 1Pertosa G,Tarantino EA,Gesualdo L,et al.C5b-9 generation and cytokine production in hemodialyzed patients. Kidney International . 1992
  • 2Wadhwa M,Thorpe R,Bird CR,et al.Production of polyclonal and monoclonal antibodies to human granulocyte colonystimulating factor (G-CSF) and development of immunoassays. Journal of Immunological Methods . 1990
  • 3Schindler R,Lonnemann G,Shaldon S,et al.Transcription notsynthesis of interleukin 1 and tumor necrosis factor bycomplement. Kidney International . 1990
  • 4Chenoweth DE,Cheung AK,Henderson LW.Anaphylatoxin formation during hemodialysis: effect of different dialyser membrane. Kidney International . 1983
  • 5Memoli B,Libetta C,Rampino T,et al.Hemodialysis related induction of interleukin-6 production by peripheral mononuclear cells. Kidney International . 1992
  • 6Bensinger WI,Price TH,Dale DC,et al.The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood . 1993
  • 7Hayashi N,Kinoshita H,Yukawa E,et al.Pharmacokinetic and pharmacodynamic analysis of subcutaneous recombinant human granulocyte colony-stimulating factor ( lenograstim )administration. Journal of Clinical Pharmacology . 1999
  • 8Panichi V,De Pietro S,Andreini B,et al.Cytokine production in haemodiafiltration: a multicentre study. Nephrology Dialysis Transplantation . 1998
  • 9Kinoshita H,Tsutsumi H,Kumakawa T,et al.Metabolic fate of rG-CSF(3). Japanese Pharmacology and Therapeutics . 1990
  • 10Tanaka HJ,Okada YJ,Kwawagishi MM,et al.Pharmacokinetics and pharmacodynamics of recombinant human granulocyte colonystimulating factor after intravenous and subcutaneous administration in the rat. Journal of Pharmacology and Experimental Therapeutics . 1989

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部